The Established Status Epilepticus Trial 2013
dc.contributor.author | Bleck, Thomas | en_US |
dc.contributor.author | Cock, Hannah | en_US |
dc.contributor.author | Chamberlain, James | en_US |
dc.contributor.author | Cloyd, James | en_US |
dc.contributor.author | Connor, Jason | en_US |
dc.contributor.author | Elm, Jordan | en_US |
dc.contributor.author | Fountain, Nathan | en_US |
dc.contributor.author | Jones, Elizabeth | en_US |
dc.contributor.author | Lowenstein, Daniel | en_US |
dc.contributor.author | Shinnar, Shlomo | en_US |
dc.contributor.author | Silbergleit, Robert | en_US |
dc.contributor.author | Treiman, David | en_US |
dc.contributor.author | Trinka, Eugen | en_US |
dc.contributor.author | Kapur, Jaideep | en_US |
dc.date.accessioned | 2013-09-04T17:18:35Z | |
dc.date.available | 2014-10-06T19:17:42Z | en_US |
dc.date.issued | 2013-09 | en_US |
dc.identifier.citation | Bleck, Thomas; Cock, Hannah; Chamberlain, James; Cloyd, James; Connor, Jason; Elm, Jordan; Fountain, Nathan; Jones, Elizabeth; Lowenstein, Daniel; Shinnar, Shlomo; Silbergleit, Robert; Treiman, David; Trinka, Eugen; Kapur, Jaideep (2013). "The Established Status Epilepticus Trial 2013." Epilepsia : 89-92. <http://hdl.handle.net/2027.42/99653> | en_US |
dc.identifier.issn | 0013-9580 | en_US |
dc.identifier.issn | 1528-1167 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/99653 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Levetiracetam | en_US |
dc.subject.other | Comparative Efficacy | en_US |
dc.subject.other | Bayesian Design | en_US |
dc.subject.other | Fosphenytoin | en_US |
dc.subject.other | Valproic Acid | en_US |
dc.title | The Established Status Epilepticus Trial 2013 | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 24001084 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/99653/1/epi12288.pdf | |
dc.identifier.doi | 10.1111/epi.12288 | en_US |
dc.identifier.source | Epilepsia | en_US |
dc.identifier.citedreference | Loddenkemper T, Goodkin HP. ( 2011 ) Treatment of pediatric status epilepticus. Curr Treat Options Neurol 13: 560 – 573. | en_US |
dc.identifier.citedreference | DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. ( 1995 ) Epidemiology of status epilepticus. J Clin Neurophysiol 12: 316 – 325. | en_US |
dc.identifier.citedreference | Connor JT, Elm JJ, Broglio KR; ESETT and ADAPT‐IT Investigators. ( 2013 ) Bayesian adaptive trials for comparative effectiveness research: an example in status epilepticus. J Clin Epidemiol 66 (Suppl. 8): S130 – S137. In Press. | en_US |
dc.identifier.citedreference | Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. ( 2012 ) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17: 3 – 23. | en_US |
dc.identifier.citedreference | Alvarez V, Januel JM, Burnand B, Rossetti AO. ( 2011 ) Second‐line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 52: 1292 – 1296. | en_US |
dc.identifier.citedreference | Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. ( 2001 ) A comparison of lorazepam, diazepam, and placebo for the treatment of out‐of‐hospital status epilepticus. N Engl J Med 345: 631 – 637. | en_US |
dc.identifier.citedreference | Towne AR. ( 2007 ) Epidemiology and outcomes of status epilepticus in the elderly. Int Rev Neurobiol 81: 111 – 127. | en_US |
dc.identifier.citedreference | Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W; NETT Investigators. ( 2012 ) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 366: 591 – 600. | en_US |
dc.identifier.citedreference | Shinnar S, Bello JA, Chan S, Hesdorffer DC, Lewis DV, Macfall J, Pellock JM, Nordli DR, Frank LM, Moshe SL, Gomes W, Shinnar RC, Sun S; FEBSTAT Study Team. ( 2012 ) MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 79: 871 – 877. | en_US |
dc.identifier.citedreference | Shinnar S, Pellock JM, Moshé SL, Maytal J, O'Dell C, Driscoll SM, Alemany M, Newstein D, DeLorenzo RJ. ( 1997 ) In whom does status epilepticus occur: age‐related differences in children. Epilepsia 38: 907 – 914. | en_US |
dc.identifier.citedreference | Nordli DR Jr, Moshé SL, Shinnar S, Hesdorffer DC, Sogawa Y, Pellock JM, Lewis DV, Frank LM, Shinnar RC, Sun S; FEBSTAT Study Team. ( 2012 ) Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study. Neurology 79: 2180 – 2186. | en_US |
dc.identifier.citedreference | Neligan A, Shorvon SD. ( 2010 ) Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol 67: 931 – 940. | en_US |
dc.identifier.citedreference | Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, Holtkamp M. ( 2010 ) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17: 348 – 355. | en_US |
dc.identifier.citedreference | DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. ( 1996 ) A prospective, population‐based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46: 1029 – 1035. | en_US |
dc.identifier.citedreference | Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. ( 1998 ) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339: 792 – 798. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.